Logo_Shanghai Haoyuan MedChemExpress_PNG-01

About Us

ChemExpress focuses on small molecule drug research and development services. For ADC development, we focus on the process development and scaling up of payloads, linkers, toxins of all kinds. We independently developed the process for MC-Val-Cit-PAB-Auristatin E, and worked with Remegen to successfully develop Disitamab Vedotin. Over 500 different kinds of linkers and payloads have been made available in-stock. Our CDMO service covers custom synthesis, scaling-up, process validation, DMF registration, CMC management, and IND filing

Passport Stamp for World ADC San Diego 2022

Passport 2022 SD (2)

Team Members

Jack

Jack Gengcheng Yang

Vice President, Business Development

Tai

Tai Zhang

Senior Manager, ADC Section

PeiPei

Peipei Zhang

Senior Manager, ADC Section

Baofu

Baofu Zheng

CEO & Founder

Qiang

Qiang Gao

General Manager & Founder

Zhinong

Zhinong Gao

President of MedChemExpress LLC

Dvaid

David Li

Vice President of Technology, Operation and Support

Lijun

Lijun Peng

Chief Operating Officer

Zhiguo

Zhiguo Zhou

Senior Manager, ADC Section

Feng

Feng Wang

Vice President, MCE & CS